Natural Killer cells in COVID-19: from Infection, to Vaccination and Therapy
Future Virology · 2023-02 · 18 (3) · 177-191
DOI: 10.2217/fvl-2022-0040 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Future Virology, online erschienen am 14.03.2023. Verfasst von Alireza Zafarani und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology & Blood Banking, School of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Natural killer (NK) cells are among the most important innate immunity members, which are the first cells that fight against infected cells. The function of these cells is impaired in patients with COVID-19 and they are not able to prevent the spread of the disease or destroy the infected cells. Few studies have evaluated the effects of COVID-19 vaccines on NK cells, though it has been demonstrated that DNA vaccines and BNT162b2 can affect NK cell response. In the present paper, the effects of SARS-CoV-2 on the NK cells during infection, the effect of vaccination on NK cells, and the NK cell-based therapies were reviewed.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology & Blood Banking, School of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran.
- Department of Virology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.
- Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran.
- Immunology Today, Universal Scientific Education & Research Network (USERN), Tehran, Iran.
- Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
- Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, 1449614535, Iran.
ORCID-Profile: Alireza Zafarani, Mohammad Hossein Razizadeh, Salar Pashangzadeh, Mohammad Reza Amirzargar, Mahsa Taghavi-Farahabadi, Mohammad Mahmoudi
Zitieren
APA
Zafarani, A., Razizadeh, M. H., Pashangzadeh, S., Amirzargar, M. R., Taghavi-Farahabadi, M., & Mahmoudi, M. (2023). Natural Killer cells in COVID-19: from Infection, to Vaccination and Therapy. Future Virology, 18(3), 177-191. https://doi.org/10.2217/fvl-2022-0040
Vancouver
Zafarani A, Razizadeh MH, Pashangzadeh S, Amirzargar MR, Taghavi-Farahabadi M, Mahmoudi M. Natural Killer cells in COVID-19: from Infection, to Vaccination and Therapy. Future Virology. 2023;18(3):177-191. doi:10.2217/fvl-2022-0040
BibTeX
@article{Zafarani2023,
author = {Zafarani, Alireza and Razizadeh, Mohammad Hossein and Pashangzadeh, Salar and Amirzargar, Mohammad Reza and Taghavi-Farahabadi, Mahsa and Mahmoudi, Mohammad},
title = {Natural Killer cells in COVID-19: from Infection, to Vaccination and Therapy},
journal = {Future Virology},
year = {2023},
volume = {18},
number = {3},
pages = {177--191},
doi = {10.2217/fvl-2022-0040}
}
EUVIMED